About 10 results found for searched term "AQ4" (0.057 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1747 | LAQ824 | HDAC |
| NVP-LAQ824 | ||
| LAQ824 (NVP-LAQ824) is a potent novel histone deacetylase (HDAC) inhibitor with an IC50 of 0.032 μM. | ||
| M3169 | Lofexidine hydrochloride | Adrenergic Receptor |
| Baq-168; MDL-14042 | ||
| Lofexidine hydrochloride is an selective α2A-adrenergic receptor agonist. | ||
| M4941 | Lomefloxacin | Antibiotic |
| Maxaquin,SC47111A | ||
| Lomefloxacin (SC47111A) is a fluoroquinolone antibiotic. | ||
| M6453 | AQ-RA 741 | Others |
| AQ-RA 741 is a selective, high affinity M 2 antagonist. | ||
| M7616 | AQ4 | Others |
| AQ4 is a chemically stable cytotoxic agent which acts as a topoisomerase II inhibitor and DNA intercalator. | ||
| M8702 | Banoxantrone dihydrochloride | Others |
| AQ4N dihydrochloride | ||
| Banoxantrone (AQ4N) is a precursor compound of the hypoxic-activated topoisomerase II inhibitor AQ4(bioreduced AQ4 precursor). | ||
| M18220 | Vitamin K2 (Menaquinone-4) | Metabolite/Endogenous Metabolite |
| Menaquinone K4 | ||
| Vitamin K2 (Menaquinone-4) is a vitamin K, used as a hemostatic agent, and also a adjunctive therapy for the pain of osteoporosis. | ||
| M28261 | Banoxantrone | NO Synthase |
| AQ4N | ||
| Banoxantrone (AQ4N), as a prototype hypoxia selective cytotoxin, can be reduced to AQ4, a potent topoisomerase II inhibitor. Banoxantrone selectively kills hypoxic cells via an iNOS-dependent mechanism. Banoxantrone shows a potent cytotoxicity and hypoxia-selective effect enhanced by radiation. | ||
| M51318 | Aquaporin-2 (254-267), pSER261, human | Others |
| Aquaporin-2 (254-267), pSER261, human is a biological active peptide. | ||
| M55419 | Menaquinone 4-d7 | Others |
| Menaquinone 4-d7 | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
